The hegemony of hotels. The role of the State in the reactivation of the profit rate of hotels after the 2008 crisis

Se analiza el ejercicio de la hegemonía empresarial hotelera para reactivar su tasa de beneficios tras la crisis de 2008. El Estado –la administración autonómica- apoyó normativamente obras y reformas hoteleras antes prohibidas, abandonando el “contencionismo” y dispensándolas del cumplimiento de ciertos parámetros normativos. Este respaldo de la regulación pública burla la preservación de los principios de igualdad o de prohibición de la arbitrariedad mediante el alegato a la superación de la crisis, desestacionalizar y a la mejora de la sostenibilidad, la accesibilidad y la seguridad. La metodología de trabajo ha consistido en el análisis de la flexibilización normativa en las Islas Baleares y estadístico y cartográfico de los datos disponibles sobre las obras de reforma y ampliación de los hoteles de Mallorca (2009-2021). Los resultados demuestran que el capital fijo inmobiliario de la industria turística de Mallorca se ha renovado y ampliado, con un aumento de 19.434 plazas entre 2010 y 2021 (superior al registrado entre 1999 y 2010, de 16.117 plazas), y el incremento de categorías e inversión en obras de nueva planta y reformas. Dichos proyectos de reforma y ampliación se concentraron en los resorts de sol y playa y la ciudad histórica de Palma. El relanzamiento del ciclo turístico fue acompañado de la rentabilidad en términos de RevPar y de revalorización del capital hotelero. Es decir, se refleja un claro vínculo entre el circuito primario y el secundario.The exercising of the hegemony of hotels is analyzed to reactivate their profit rate after the 2008 crisis. The State (regional administration) normatively supported previously prohibited hotel works and reforms, abandoning "contentionism" and exempting them from complying with certain regulatory parameters. This support of public regulation circumvents the preservation of the principles of equality or the prohibition of arbitrariness by alleging to overcome the crisis, deseasonalize and improve sustainability, accessibility and safety. Our methodology consists in analyzing the regulatory flexibility in the Balearic Islands and the statistical and cartographic analysis of the available data on the renovation and expansion works of the hotels in Mallorca (2009-2021). The results show that the real estate fixed capital of the tourism industry in Mallorca has been renewed and expanded, with an increase of 19,434 places between 2010 and 2021 (higher than that 16,117 places registered between 1999 and 2010), and an increase in categories and investment in new constructions and reforms. These renovation and expansion projects are focused on the sun and beach tourist resorts and the historic city of Palma. The relaunch of the tourism cycle was accompanied by profitability in terms of RevPar and revaluation of hotel capital. In other words, a clear link is reflected between the primary and secondary circuits.Esta publicación es parte del proyecto de I+D+i RTI2018-094844-B-C31 financiado/a por MCIN/AEI/10.13039/501100011033 y por “FEDER Una manera de hacer Europa”, con el apoyo también de la Comunidad Autónoma de las Islas Baleares, a través de la Dirección General de Política Universitaria e Investigación con fondos de la Ley 2/2016, de 30 de marzo, del impuesto sobre estancias turísticas en las Islas Baleares y de medidas de impulso del turismo sostenible (PPDR2020/82 - ITS2017-006)

Why Are Outcomes Different for Registry Patients Enrolled Prospectively and Retrospectively? Insights from the Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF).

Background: Retrospective and prospective observational studies are designed to reflect real-world evidence on clinical practice, but can yield conflicting results. The GARFIELD-AF Registry includes both methods of enrolment and allows analysis of differences in patient characteristics and outcomes that may result. Methods and Results: Patients with atrial fibrillation (AF) and ≥1 risk factor for stroke at diagnosis of AF were recruited either retrospectively (n = 5069) or prospectively (n = 5501) from 19 countries and then followed prospectively. The retrospectively enrolled cohort comprised patients with established AF (for a least 6, and up to 24 months before enrolment), who were identified retrospectively (and baseline and partial follow-up data were collected from the emedical records) and then followed prospectively between 0-18 months (such that the total time of follow-up was 24 months; data collection Dec-2009 and Oct-2010). In the prospectively enrolled cohort, patients with newly diagnosed AF (≤6 weeks after diagnosis) were recruited between Mar-2010 and Oct-2011 and were followed for 24 months after enrolment. Differences between the cohorts were observed in clinical characteristics, including type of AF, stroke prevention strategies, and event rates. More patients in the retrospectively identified cohort received vitamin K antagonists (62.1% vs. 53.2%) and fewer received non-vitamin K oral anticoagulants (1.8% vs . 4.2%). All-cause mortality rates per 100 person-years during the prospective follow-up (starting the first study visit up to 1 year) were significantly lower in the retrospective than prospectively identified cohort (3.04 [95% CI 2.51 to 3.67] vs . 4.05 [95% CI 3.53 to 4.63]; p = 0.016). Conclusions: Interpretations of data from registries that aim to evaluate the characteristics and outcomes of patients with AF must take account of differences in registry design and the impact of recall bias and survivorship bias that is incurred with retrospective enrolment. Clinical Trial Registration: - URL: http://www.clinicaltrials.gov . Unique identifier for GARFIELD-AF (NCT01090362)

A922 Sequential measurement of 1 hour creatinine clearance (1-CRCL) in critically ill patients at risk of acute kidney injury (AKI)

Meeting abstrac

Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry.

BACKGROUND: The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) is an ongoing prospective noninterventional registry, which is providing important information on the baseline characteristics, treatment patterns, and 1-year outcomes in patients with newly diagnosed non-valvular atrial fibrillation (NVAF). This report describes data from Indian patients recruited in this registry. METHODS AND RESULTS: A total of 52,014 patients with newly diagnosed AF were enrolled globally; of these, 1388 patients were recruited from 26 sites within India (2012-2016). In India, the mean age was 65.8 years at diagnosis of NVAF. Hypertension was the most prevalent risk factor for AF, present in 68.5% of patients from India and in 76.3% of patients globally (P < 0.001). Diabetes and coronary artery disease (CAD) were prevalent in 36.2% and 28.1% of patients as compared with global prevalence of 22.2% and 21.6%, respectively (P < 0.001 for both). Antiplatelet therapy was the most common antithrombotic treatment in India. With increasing stroke risk, however, patients were more likely to receive oral anticoagulant therapy [mainly vitamin K antagonist (VKA)], but average international normalized ratio (INR) was lower among Indian patients [median INR value 1.6 (interquartile range {IQR}: 1.3-2.3) versus 2.3 (IQR 1.8-2.8) (P < 0.001)]. Compared with other countries, patients from India had markedly higher rates of all-cause mortality [7.68 per 100 person-years (95% confidence interval 6.32-9.35) vs 4.34 (4.16-4.53), P < 0.0001], while rates of stroke/systemic embolism and major bleeding were lower after 1 year of follow-up. CONCLUSION: Compared to previously published registries from India, the GARFIELD-AF registry describes clinical profiles and outcomes in Indian patients with AF of a different etiology. The registry data show that compared to the rest of the world, Indian AF patients are younger in age and have more diabetes and CAD. Patients with a higher stroke risk are more likely to receive anticoagulation therapy with VKA but are underdosed compared with the global average in the GARFIELD-AF. CLINICAL TRIAL REGISTRATION-URL: http://www.clinicaltrials.gov. Unique identifier: NCT01090362

Global balearization: tourist capital in the abatement and instrumentation of the State

Se analiza la relación entre las cadenas hoteleras de matriz Balear y el Estado, en el contexto del capitalismo neoliberal. Se presentan casos de estudio de minoración e instrumentación de la democracia y del Estado por parte de las mencionadas cadenas hoteleras: en las Islas Baleares, con la campaña política contra la ecotasa (1999‐2003) y su corolario de regulación turística; y en su internacionalización turístico‐inmobiliaria a partir de los años ochenta, en el Sur Global. La articulación política del empresariado hotelero de las Islas Baleares contribuye a evidenciar el creciente dominio hegemónico del capital, sometiendo a la sociedad a su proyecto de clase, en una secuela de balearización global.This paper attempts to analyse the relationship between the Balearic hotel chains and the State, in the context of neoliberal capitalism. Several case studies of the instrumentation of the State by those corporations are studied, as well as the contribution of tourist capital to the abatement of the State: in the Balearic Islands, the campaign against the tourist tax called “ecotax” (1999‐2003); and in their tourist‐real estate internationalization from the '80s onwards to the Global South. The political articulation of the great hoteliers from the Balearic Islands helps to highlight the growing hegemony of capital with the submission of society to their class project, and this can be understood as a sequel of the global balearization.Este artículo se basa en el proyecto de investigación titulado “La geoeconomía y la geopolítica turística. Análisis de la glocalización turística balear, implicaciones socioambientales” (CSO2009-08400) del Ministerio de Ciencia e Innovación

Ciutats, territoris metropolitans i regions urbanes eficients : la Regió Metropolitana de Barcelona com a laboratori

Descripció del recurs:23 de novembre de 2016Altres mencions de responsabilitat a la pàg. 664: Antonio Font, Konstantinos Kourkoutas, Lorena Maristany, Sílvia Mas, Xavier Mayor, Ivan Muñiz, Mosè Ricci, Paolo Ceccarelli, Sofia MorgadoA la part inferior de la portada: "Proyectos de Investigación Fundamental no orientada, Plan Nacional 2012 ; CMT Ciutat Mosaic Territorial ; DUOT Departament d'Urbanisme i Ordenació del Territori ; Universitat Politècnica de Catalunya, BarcelonaTech ; Gobierno de España, Ministerio de Economía y Competitividad ; Unión Europea, Fondo Europeo de Desarrollo Regional"Títol paral·lel en català obtingut de la pàgina de crèditsText en català i en castellàAquesta publicació és part del resultat del projecte de recerca nacional anomenat “Ciudades, territorios metropolitanos y regiones urbanas eficientes. Estrategias y propuestas de proyecto para la regeneración de la ciudad_mosaico_territorial después de la explosión de la ciudad”, finançat pel Ministeri d’Economia i Competitivitat del Govern d’Espanya i la Unió Europea. El marc temporal de la recerca el situem, doncs, en el període 1977-2012 pel que fa al registre de les transformacions territorials; i entre el 1985 i el 2015 pel registre d’actuacions i propostes metropolitanes, de les quals es prioritzen per ser estudiades les compreses entre 2007 i 2012